Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
I-ne, 8% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term, Dividend Raised by 0.5 yen
4933 I-ne CO., LTD. 【J-GAAP】
Earnings ReportI-ne CO., LTD. <4933> [TSE Prime] announced its financial results after the market closed on February 12th (15:30). The consolidated ordinary profit for the fiscal year ending December 2024 increased 6.5% from the previous period to 4.62 billion yen. In the fiscal year ending December 2025, the profit is expected to grow by 8.2% to 5 billion yen, marking the eighth consecutive term of record-high profits. This will be the seventh consecutive term of revenue and profit growth.
At the same time, the company has decided to increase the dividend this fiscal year to 13.5 yen, an increase of 0.5 yen from the previous fiscal year.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit grew 29.2% from the same period last year, reaching 1.67 billion yen. However, the operating profit margin remained almost flat, changing from 11.9% in the same period last year to 11.9%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 35,269 | 3,235 | 3,469 | 1,927 | 110.2 | 0 | Feb 10, 2023 | J-GAAP |
Dec, 2023 | 41,643 | 4,379 | 4,337 | 3,954 | 224.4 | 13 | Feb 9, 2024 | J-GAAP |
Dec, 2024 | 45,006 | 4,583 | 4,621 | 2,938 | 167.0 | 13 | Feb 12, 2025 | J-GAAP |
YoY | +8.1% | +4.7% | +6.5% | -25.7% | -25.6% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 45,800 | 4,600 | 4,550 | 2,400 | 137.3 | 13 | Nov 8, 2024 | J-GAAP |
Dec, 2024 Results | 45,006 | 4,583 | 4,621 | 2,938 | 167.0 | 13 | Feb 12, 2025 | J-GAAP |
Revision Rate | -1.7% | -0.4% | +1.6% | +22.4% | +21.7% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 20,311 | 2,034 | 2,143 | 1,241 | 70.2 | 0 | Aug 9, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | 23,000 | 1,530 | 1,480 | 720 | 41.2 | 0 | Feb 12, 2025 | J-GAAP |
YoY | +13.2% | -24.8% | -30.9% | -42.0% | -41.3% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 41,643 | 4,379 | 4,337 | 3,954 | 224.4 | 13 | Feb 9, 2024 | J-GAAP |
Dec, 2024 | 45,006 | 4,583 | 4,621 | 2,938 | 167.0 | 13 | Feb 12, 2025 | J-GAAP |
Dec, 2025 Guidance | 52,000 | 5,040 | 5,000 | 2,700 | 154.4 | 13.50 | Feb 12, 2025 | J-GAAP |
YoY | +15.5% | +10.0% | +8.2% | -8.1% | -7.6% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 11,175 | 1,330 | 1,293 | 378 | 21.5 | 11.9 | Feb 9, 2024 | J-GAAP |
Jan - Mar, 2024 | 9,082 | 638 | 705 | 426 | 24.0 | 7.0 | May 10, 2024 | J-GAAP |
Apr - Jun, 2024 | 11,229 | 1,396 | 1,438 | 815 | 46.1 | 12.4 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 10,999 | 923 | 807 | 335 | 19.0 | 8.4 | Nov 8, 2024 | J-GAAP |
Oct - Dec, 2024 | 13,696 | 1,626 | 1,671 | 1,362 | 77.4 | 11.9 | Feb 12, 2025 | J-GAAP |
YoY | +22.6% | +22.3% | +29.2% | +260.3% | +261.0% |
Related Articles
JSH, The Current Fiscal Year Ordinary Profit Revised Downward by 4%
PCI Holdings, Oct-Dec (1Q) Ordinary Profit Increases by 67%
Japan Display, The Current Fiscal Year Net Income Loss Widened in Downward Revision, 72% Deficit Against Net Assets
eREX, Oct-Dec (3Q) Net Income Turns to Profit, The Undetermined Dividend Set at 11 yen, Resuming Dividends for the First Time in Two Terms
Photosynth, 76% Increase in Ordinary Profit, Update Record High for Second Consecutive Term
Recovery International, 1% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term
FUSO DENTSU, Oct-Dec (1Q) Ordinary Profit Decreases by 6%
C.I. MEDICAL, 63% Increase in Ordinary Profit for The Current Fiscal Year
Kubota Pharma, Last Fiscal Year's Undisclosed Net Income to Narrow
Moriya Transportation Engineering, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 60%, Oct-Dec Ordinary Profit Increases by 54%